Neuronetics, Inc..
American company
- Reports this week
- 0
- Active events
- 0
- Connections
- 21
What's happening
One to three months ago
-
Neuronetics, Inc. operates Greenbrook treatment centers across the US and Keith Sullivan serves as its President and CEO.Some support2 reports1 development inside
-
Cory Anderson was promoted to EVP/GM of Greenbrook clinics, and Rob Greene was appointed Senior VP of Sales at Neuronetics, Inc.Some support1 report
Gone quiet
No new reports in 90+ days-
Steven Pfanstiel was appointed as the new Chief Financial Officer of Neuronetics, Inc., replacing Steve Furlong.Some support1 report
-
Neuronetics, Inc. reported that its revenue forecast growth exceeded the industry average.Some support1 report
-
TMS manufacturer Neuronetics gained FDA clearance for its NeuroStar system for use in adolescents.Some support4 reports
No events began in the chosen period. Widen it, or reset.
Around Neuronetics, Inc. this week
News at the entities that move Neuronetics, Inc. most-
FDA StructuralFDA rated generic equivalent to brand Climara Pro.Moves Neuronetics, Inc.
-
Royal Bank of Canada StructuralRBC, Keefe, Bruyette & Woods, and Morgan Stanley issued rating and price target updates for D.R. Horton, Inc.Moves Neuronetics, Inc.
-
SEC StructuralKahn Brothers Group Inc. purchased a stake in First National Bank Alaska, which operates in Alaska and files reports with the SEC.Moves Neuronetics, Inc.
-
Rockville Shared contextPortia Wu and Wes Moore toured Sunflower Bakery in Rockville on October 14, 2026.Moves Neuronetics, Inc.
Connections
The 8 strongest of 21, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Cory Anderson Structural
Cory Anderson serves as a senior executive (CTO) at Neuronetics, Inc.
-
Keith Sullivan Structural
Keith Sullivan serves as the President and CEO of Neuronetics, Inc.
-
TMS Structural
Neuronetics utilizes TMS technology as the core system for developing and marketing its mental health treatments.
-
Royal Bank of Canada Structural
Royal Bank of Canada increased its financial stake in Neuronetics, establishing an ownership relationship.
-
Rob Greene Structural
Rob Greene holds the position of Senior VP of Sales at Neuronetics, Inc.
-
FDA Structural
The FDA grants regulatory clearance for Neuronetics' NeuroStar product.
-
SEC Structural
Neuronetics operates under SEC rules requiring major shareholders to disclose trades with the commission.
-
Rockville Shared context
Neuronetics established a presence in Rockville by opening a National Center of Excellence.
History
Events by the month they beganAugust 2026
1 eventJune 2026
4 events- Neuronetics, Inc. operates Greenbrook treatment centers across the US and Keith Sullivan serves as its President and CEO.
- Steven Pfanstiel was appointed as the new Chief Financial Officer of Neuronetics, Inc., replacing Steve Furlong.
- Neuronetics, Inc. reported that its revenue forecast growth exceeded the industry average.
- TMS manufacturer Neuronetics gained FDA clearance for its NeuroStar system for use in adolescents.